From a diabetes drug hopes to fight obesity

A new opportunity arises for the obesity challenge. After 72 weeks of treatment with one drug, tirzepatide, there was a 20.9% drop in body weight. The drug is not yet available in Italy either for diabetes or for the treatment of obesity. The results of the SURMOUNT-1 study, coordinated by Ania Jastreboffdirector of Weight Management & Obesity Prevention at Yale University, presented at the American Diabetes Association (ADA) 2022 convention and published in the New England Journal of Medicine.